Raia Drogasil (OTCMKTS:RADLY) Sees Unusually-High Trading Volume – Should You Buy?

Raia Drogasil S.A. (OTCMKTS:RADLY) shares saw strong trading volume on Tuesday . 395,106 shares changed hands during mid-day trading, an increase of 521% from the previous session’s volume of 63,579 shares.The stock last traded at $3.7326 and had previously closed at $3.7490.

Raia Drogasil Stock Performance

The firm has a fifty day moving average price of $3.67 and a 200 day moving average price of $3.99. The company has a current ratio of 1.41, a quick ratio of 0.58 and a debt-to-equity ratio of 0.99.

Raia Drogasil (OTCMKTS:RADLY) last announced its quarterly earnings data on Tuesday, August 4th. The company reported $0.05 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.05. Raia Drogasil had a net margin of 2.97% and a return on equity of 18.20%. The firm had revenue of $2.17 billion during the quarter, compared to analyst estimates of $2.32 billion. Sell-side analysts expect that Raia Drogasil S.A. will post 0.17 earnings per share for the current fiscal year.

Raia Drogasil Company Profile

Raia Drogasil, now operating under the brand name RD Saúde, is a Brazilian healthcare and pharmacy retail company. It operates a nationwide network of pharmacies that sells prescription and over-the-counter medicines, personal-care products, cosmetics, health and wellness items, and convenience products.

The company also provides digital shopping and delivery services through its online channels, supporting customers with medication and health-related purchases. Its operations combine physical stores with e-commerce and other healthcare-related services, serving consumers throughout Brazil.

RD Saúde was formed in 2011 through the merger of Drogasil and Droga Raia, two pharmacy chains with roots dating back to the early twentieth century.